loading page

Paradoxical Diabetic Ketoacidosis in a Type 2 Diabetes patient on Dapagliflozin: A Brief Case Report
  • Venkata Vinod Kumar Matli
Venkata Vinod Kumar Matli
SUNY Upstate Medical University

Corresponding Author:drvinmatli@yahoo.com

Author Profile


A 48-year -old male patient with Type 2 diabetes mellitus(T2D) on insulin replacement therapy, glipizide and Dapagliflozin admitted for generalized weakness found him in euglycemic diabetic ketoacidosis which means normal or near normal glucose levels with high anion gap metabolic acidosis recovered on insulin drip per DKA protocol.
22 Jul 2021Submitted to Clinical Case Reports
23 Jul 2021Submission Checks Completed
23 Jul 2021Assigned to Editor
26 Jul 2021Reviewer(s) Assigned
02 Aug 2021Review(s) Completed, Editorial Evaluation Pending
14 Aug 2021Editorial Decision: Revise Minor
20 Aug 20211st Revision Received
24 Aug 2021Submission Checks Completed
24 Aug 2021Assigned to Editor
24 Aug 2021Review(s) Completed, Editorial Evaluation Pending
09 Sep 2021Editorial Decision: Accept